搜尋
產品
社群
市場
新聞
經紀商
更多
TW
立即開始
Long on ACAD - Upgraded Target to $35.00 level
看多
ACADIA Pharmaceuticals Inc.
(
NASDAQ:ACAD
)
Economist
Premium
NASDAQ:ACAD
ACADIA Pharmaceuticals Inc.
0
0
This is more of a personal play as I have been long since the stock was trading below $3.00. There is a strong possibility this recent test of support, just below the $27.00 level, initiates the continuation of the price climb.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款
閱讀更多資訊。